CytoDyn Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CytoDyn Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • CytoDyn Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 30, 2024 was 1.22B shares, a 31% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.22B +289M +31% Sep 30, 2024 10-Q 2024-10-15
Q2 2024 1.21B Jul 31, 2024 10-K/A 2024-09-30
Q1 2024 993M +80.9M +8.86% Mar 31, 2024 10-Q 2024-04-15
Q4 2023 980M +147M +17.6% Dec 31, 2023 10-Q 2024-01-16
Q3 2023 931M +118M +14.6% Sep 30, 2023 10-Q 2023-10-23
Q1 2023 913M +194M +27% Mar 31, 2023 10-Q 2023-04-10
Q4 2022 833M +143M +20.7% Dec 31, 2022 10-Q 2023-01-09
Q3 2022 813M +153M +23.1% Sep 30, 2022 10-Q/A 2022-10-13
Q2 2022 811M +178M +28.2% Jul 31, 2022 10-K 2022-08-15
Q1 2022 718M +105M +17.2% Mar 31, 2022 10-Q 2022-04-11
Q4 2021 690M +92.1M +15.4% Dec 31, 2021 10-Q 2022-01-10
Q3 2021 660M +89.4M +15.7% Sep 30, 2021 10-Q 2021-10-12
Q2 2021 633M +64.3M +11.3% Jul 15, 2021 10-K/A 2021-09-28
Q1 2021 613M +131M +27.1% Mar 31, 2021 10-Q 2021-04-14
Q4 2020 598M +167M +38.9% Dec 31, 2020 10-Q 2021-01-08
Q3 2020 571M +182M +47% Sep 30, 2020 10-Q 2020-10-09
Q2 2020 568M +203M +55.8% Jul 31, 2020 10-K 2020-08-14
Q1 2020 482M +177M +57.8% Mar 31, 2020 10-Q 2020-04-09
Q4 2019 431M +138M +47.1% Dec 31, 2019 10-Q 2020-01-09
Q3 2019 388M +132M +51.8% Oct 4, 2019 10-Q 2019-10-08
Q2 2019 365M +146M +66.8% Jun 30, 2019 10-K 2019-08-14
Q1 2019 305M +93.4M +44% Mar 31, 2019 10-Q 2019-04-09
Q4 2018 293M +123M +72.4% Dec 31, 2018 10-Q 2019-01-09
Q3 2018 256M +99.7M +63.8% Sep 28, 2018 10-Q 2018-10-09
Q2 2018 219M +65.9M +43.2% Jun 30, 2018 10-K 2018-07-27
Q1 2018 212M +62.6M +41.9% Mar 31, 2018 10-Q 2018-04-09
Q4 2017 170M +27.6M +19.4% Dec 31, 2017 10-Q 2018-01-08
Q3 2017 156M +17.9M +12.9% Sep 30, 2017 10-Q 2017-10-10
Q2 2017 153M +28.2M +22.7% Jun 30, 2017 10-K 2017-07-20
Q1 2017 149M +31.1M +26.3% Mar 31, 2017 10-Q 2017-04-13
Q4 2016 142M +43.3M +43.7% Dec 31, 2016 10-Q 2017-01-13
Q3 2016 138M +54.5M +65.1% Sep 30, 2016 10-Q 2016-10-12
Q2 2016 125M +54.4M +77.5% Jun 30, 2016 10-K 2016-07-19
Q1 2016 118M +54.9M +86.6% Mar 31, 2016 10-Q 2016-04-13
Q4 2015 98.9M +40.2M +68.5% Dec 31, 2015 10-Q 2016-01-11
Q3 2015 83.7M +27.9M +50.1% Sep 30, 2015 10-Q 2015-10-09
Q2 2015 70.1M +14.4M +25.8% Jun 30, 2015 10-K 2015-07-10
Q1 2015 63.4M +7.87M +14.2% Mar 31, 2015 10-Q 2015-04-10
Q4 2014 58.7M +3.4M +6.14% Dec 31, 2014 10-Q 2015-01-12
Q3 2014 55.8M +16.1M +40.7% Sep 30, 2014 10-Q 2014-10-10
Q2 2014 55.8M +25M +81% Jun 30, 2014 10-K 2014-07-10
Q1 2014 55.6M +24.7M +79.9% Mar 31, 2014 10-Q 2014-04-11
Q4 2013 55.3M +25.3M +84.4% Dec 31, 2013 10-Q 2014-01-13
Q3 2013 39.6M +9.73M +32.5% Sep 30, 2013 10-Q 2013-10-15
Q2 2013 30.8M +1.59M +5.43% Jul 31, 2013 10-K 2013-08-29
Q1 2013 30.9M +2.42M +8.52% Apr 1, 2013 10-Q 2013-04-12
Q4 2012 30M +7.73M +34.7% Jan 3, 2013 10-Q 2013-01-14
Q3 2012 29.9M Sep 30, 2012 10-Q/A 2012-11-08
Q2 2012 29.2M Jul 31, 2012 10-K 2012-08-22
Q1 2012 28.5M Apr 1, 2012 10-Q 2012-04-16
Q4 2011 22.3M Jan 17, 2012 10-Q 2012-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.